Curis CRIS
NASDAQ CRIS
$1.58 -0.03 (-1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Curis (CRIS) Other Accumulated Expenses (2011 - 2016)

Curis' (CRIS) quarterly Other Accumulated Expenses came in at $226000.0 in Q2 2016, up 17.92% YoY from $191659.0 in Q3 2015, and up 17.61% on a QoQ basis from $192164.0 in Q1 2016.

Curis (CRIS) Other Accumulated Expenses (2011 - 2016) Analysis & Trends

Curis (CRIS) has 6 years of Other Accumulated Expenses data on file, last reported at $226000.0 in Q2 2016.

  • Quarterly Other Accumulated Expenses rose 17.92% year-over-year to $226000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $226000.0 (up 17.92% YoY) and the FY2015 annual result came in at $249000.0, up 17.15% from the prior year.
  • Other Accumulated Expenses climbed to $226000.0 in Q2 2016, from $192164.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $249000.0 in Q4 2015 to a low of $115518.0 in Q2 2012.
  • A 5-year average of $183073.9 and a median of $188862.0 in 2015 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2013 — Other Accumulated Expenses surged 86.06% — and 2014, when it decreased 22.71%.
  • Tracing CRIS's Other Accumulated Expenses over 5 years: stood at $143851.0 in 2012, then climbed by 24.01% to $178390.0 in 2013, then rose by 19.15% to $212548.0 in 2014, then rose by 17.15% to $249000.0 in 2015, then declined by 9.24% to $226000.0 in 2016.
  • The last three Other Accumulated Expenses figures came in at $226000.0 (Q2 2016), $192164.0 (Q1 2016), and $249000.0 (Q4 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Curis 3.27 Mn -2.35 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2016 226,000.00
Mar 31, 2016 192,164.00
Dec 31, 2015 249,000.00
Sep 30, 2015 186,670.00
Jun 30, 2015 191,659.00
Mar 31, 2015 188,862.00
Dec 31, 2014 212,548.00
Sep 30, 2014 195,116.00
Jun 30, 2014 166,116.00
Mar 31, 2014 207,022.00
Dec 31, 2013 178,390.00
Sep 30, 2013 134,527.00
Jun 30, 2013 214,937.00
Mar 31, 2013 160,020.00
Dec 31, 2012 143,851.00
Sep 30, 2012 149,857.00
Jun 30, 2012 115,518.00
Dec 31, 2011 166,037.00